---
title: "CDT Equity Inc. (CDT.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CDT.US.md"
symbol: "CDT.US"
name: "CDT Equity Inc."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-19T14:07:11.307Z"
locales:
  - [en](https://longbridge.com/en/quote/CDT.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CDT.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CDT.US.md)
---

# CDT Equity Inc. (CDT.US)

## Company Overview

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | US Market |
| Website | [www.cdtequity.com](https://www.cdtequity.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.19 | 25 | - | - | - |
| PB | -1.02 | 54 | 1.34 | 0.65 | 0.39 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CDT.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CDT.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CDT.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CDT.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**